Marshall Wace’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $48.5M | Sell |
562,630
-413,266
| -42% | -$37.1M | 0.05% | 370 |
|
|
2025
Q4 | $85.2M | Sell |
975,896
-736,013
| -43% | -$55.9M | 0.08% | 206 |
|
|
2025
Q3 | $98M | Buy |
1,711,909
+131,433
| +8% | +$7.57M | 0.1% | 170 |
|
|
2025
Q2 | $93.3M | Buy |
1,580,476
+747,330
| +90% | +$48.3M | 0.11% | 177 |
|
|
2025
Q1 | $61M | Sell |
833,146
-303,120
| -27% | -$25M | 0.08% | 232 |
|
|
2024
Q4 | $94M | Buy |
1,136,266
+486,756
| +75% | +$38.4M | 0.11% | 162 |
|
|
2024
Q3 | $46.5M | Sell |
649,510
-308,224
| -32% | -$21.8M | 0.06% | 297 |
|
|
2024
Q2 | $65.6M | Sell |
957,734
-271,706
| -22% | -$16.2M | 0.09% | 216 |
|
|
2024
Q1 | $65.9M | Sell |
1,229,440
-405,130
| -25% | -$21.8M | 0.1% | 198 |
|
|
2023
Q4 | $87.1M | Buy |
1,634,570
+248,492
| +18% | +$12.1M | 0.15% | 138 |
|
|
2023
Q3 | $68.8M | Buy |
1,386,078
+637,959
| +85% | +$35.7M | 0.14% | 145 |
|
|
2023
Q2 | $44.5M | Sell |
748,119
-774,372
| -51% | -$44.1M | 0.09% | 242 |
|
|
2023
Q1 | $86.2M | Buy |
+1,522,491
| New | +$97.6M | 0.18% | 120 |
|
|
2020
Q4 | – | Sell |
-13,346
| Closed | -$661K | – | 1988 |
|
|
2020
Q3 | $661K | Buy |
+13,346
| New | +$688K | ﹤0.01% | 1160 |
|
|
2019
Q3 | – | Sell |
-116,146
| Closed | -$4.91M | – | 1764 |
|
|
2019
Q2 | $4.91M | Buy |
116,146
+36,814
| +46% | +$1.6M | 0.04% | 489 |
|
|
2019
Q1 | $3.92M | Sell |
79,332
-299,987
| -79% | -$13.6M | 0.04% | 542 |
|
|
2018
Q4 | $16.4M | Sell |
379,319
-481,389
| -56% | -$24M | 0.17% | 140 |
|
|
2018
Q3 | $48.9M | Buy |
+860,708
| New | +$45.3M | 0.42% | 44 |
|
|
2017
Q1 | – | Sell |
-544,217
| Closed | -$13.5M | – | 470 |
|
|
2016
Q4 | $13.5M | Buy |
544,217
+522,870
| +2,449% | +$11.9M | 0.09% | 261 |
|
|
2016
Q3 | $482K | Sell |
21,347
-37,883
| -64% | -$890K | ﹤0.01% | 804 |
|
|
2016
Q2 | $1.41M | Buy |
59,230
+20,490
| +53% | +$491K | 0.01% | 657 |
|
|
2016
Q1 | $920K | Buy |
+38,740
| New | +$947K | 0.01% | 735 |
|
|
2015
Q4 | – | Sell |
-601,529
| Closed | -$12.4M | – | 1027 |
|
|
2015
Q3 | $12.4M | Buy |
601,529
+265,997
| +79% | +$6.74M | 0.15% | 153 |
|
|
2015
Q2 | $8.61M | Buy |
335,532
+272,385
| +431% | +$6.9M | 0.11% | 200 |
|
|
2015
Q1 | $1.59M | Sell |
63,147
-57,869
| -48% | -$1.41M | 0.02% | 503 |
|
|
2014
Q4 | $2.88M | Sell |
121,016
-168,094
| -58% | -$3.72M | 0.04% | 397 |
|
|
2014
Q3 | $5.69M | Buy |
289,110
+41,729
| +17% | +$859K | 0.08% | 268 |
|
|
2014
Q2 | $5.92M | Buy |
247,381
+242,849
| +5,359% | +$5.86M | 0.09% | 247 |
|
|
2014
Q1 | $121K | Buy |
+4,532
| New | +$108K | ﹤0.01% | 754 |
|
Other funds holding GMED
VCM
VPM
SC
Marshall Wace's GMED Position: Q1 2026 in Review
Marshall Wace reduced its Globus Medical (GMED) stake by 42% in Q1 2026, selling an estimated $37.1M and leaving 562,630 shares worth $48.5M. The position accounts for 0.05% of the portfolio, ranked #370.
Marshall Wace first reported a position in GMED in Q1 2014 and has held it in 29 quarters since. The position peaked at $98M in Q3 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.
- Marshall Wace held 562,630 shares of Globus Medical worth $48.5M as of Q1 2026.
- Marshall Wace sold 413,266 Globus Medical shares in Q1 2026, an estimated $37.1M.
- Globus Medical made up 0.05% of Marshall Wace's portfolio in Q1 2026, its #370 holding.
- Marshall Wace first reported a position in Globus Medical in Q1 2014 and has held it in 29 quarters since.
- Marshall Wace's Globus Medical position peaked at $98M in Q3 2025.
- 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.